OMX30 1 618 -1,0%  OMXH25 3 936 -0,3%  OMXC20 1 002 -0,2%  Dow 23 358 -0,4%  Nas 6 315 -0,4%  EUR 9,9396 0,0%  USD 8,4326 0,0%  Olja 62,7 2,2%  Guld 1 294 1,4% 

Edwards Lifesciences Aktie

107,10USD 0,00USD 0,00%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Edwards Lifesciences Chart - 1 År - BTT

Fundamentala nyckeltal för Edwards Lifesciences

2016 2017e 2018e 2019e 2020e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 32,30 29,01 26,09 23,18 21,20
Resultat/aktie 2,89 3,75 4,17 4,69 5,13

Nyheter om Edwards Lifesciences Corp.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Edwards Lifesciences Corp.

ytterligare analyser

Edwards Lifesciences Peer Group

Edwards Lifesciences 107,10
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Edwards Lifesciences Corp.till bolagsprofilen

Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Critical Care portfolio products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Realtidskurs Edwards Lifesciences Corp.

Bid 106,63 USD Ask 107,70 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Edwards Lifesciences Corp. i USDPUSH CHART

Kurs 107,10 USD 0,00 0,00 %
Kurstid 21:59:59
Datum 17.11.2017
Öppning 106,46
Gårdagen 107,10
Dagshögsta 107,77
Dagslägsta 106,14
52 v. högsta 121,45
52 v. lägsta 81,12
52 v. perf.
Volym (Antal) 74 086
Börsvärde (SEK) 189,72 Mrd
Börsen
Kurs för 107,10 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 903,13 SEK.

Till aktien Edwards Lifesciences

Ticker
ISIN US28176E1082
Index S&P 500

Edwards Lifesciences Nyckeltal

Börsvärde i SEK 189,72 Mrd
Free float % 99,20
Antal aktier mio. 211,62
Cashflow/aktie i lokal valuta 3,18
Bokvärde/aktie i lokal valuta 12,57
60 dagar vola 30,76
PBV 7,43

Edwards Lifesciences Historiska kurser

2017-11-17 107,10 74 086
2017-11-16 107,10 43 325
2017-11-15 104,98 69 236
2017-11-14 105,18 56 457
2017-11-13 105,21 50 515